Ni-kshay Poshan Yojana: receipt and utilization among persons with TB notified under the National TB Elimination Program in India, 2022.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
ACS Applied Bio Materials Pub Date : 2024-12-31 Epub Date: 2024-07-22 DOI:10.1080/16549716.2024.2363300
Kathiresan Jeyashree, Jeromie W V Thangaraj, Devika Shanmugasundaram, G Sri Lakshmi Priya, Sumit Pandey, Venkateshprabhu Janagaraj, Prema Shanmugasundaram, Sumitha Ts, Sabarinathan Ramasamy, Joshua Chadwick, Sivavallinathan Arunachalam, Rahul Sharma, Vaibhav Shah, Aniket Chowdhury, Swati Iyer, Raghuram Rao, Sanjay K Mattoo, Manoj V Murhekar, Npy Evaluation Group
{"title":"<i>Ni-kshay Poshan Yojana</i>: receipt and utilization among persons with TB notified under the National TB Elimination Program in India, 2022.","authors":"Kathiresan Jeyashree, Jeromie W V Thangaraj, Devika Shanmugasundaram, G Sri Lakshmi Priya, Sumit Pandey, Venkateshprabhu Janagaraj, Prema Shanmugasundaram, Sumitha Ts, Sabarinathan Ramasamy, Joshua Chadwick, Sivavallinathan Arunachalam, Rahul Sharma, Vaibhav Shah, Aniket Chowdhury, Swati Iyer, Raghuram Rao, Sanjay K Mattoo, Manoj V Murhekar, Npy Evaluation Group","doi":"10.1080/16549716.2024.2363300","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Ni-kshay Poshan Yojana</i> (NPY), a direct benefit transfer scheme under the National Tuberculosis Elimination Program (NTEP) in India, provides a monthly benefit of INR500 for nutritional support of persons with TB (PwTB).</p><p><strong>Objectives: </strong>To determine the proportion of PwTB receiving atleast one NPY instalment and pattern of utilisation; to ascertain factors associated with NPY non-receipt and association of NPY receipt with TB treatment outcome.</p><p><strong>Methods: </strong>In our cross-sectional study, we used multi-stage sampling to select PwTB whose treatment outcome was declared between May 2022 and February 2023. A cluster-adjusted, generalized linear model was used to identify factors associated with the non-receipt of NPY and determine association between NPY receipt and TB treatment outcome.</p><p><strong>Results: </strong>Among 3201 PwTB, 2888 (92.7%; 95% CI 89.8%, 94.8%) had received at least one NPY instalment, and 1903 (64.2%; 95% CI 58.9%, 69.2%) self-reported receipt of benefit. The median (IQR) time to receipt of first instalment was 105 (60,174) days. Non-receipt was significantly higher among PwTB from states with low TB score (aPR = 2.34; 95%CI 1.51, 3.62), who do not have bank account (aPR = 2.48; 95%CI 1.93, 3.19) and with unknown/missing diabetic status (aPR = 1.69; 95%CI 1.11, 2.55). Unfavorable treatment outcomes were associated with non-receipt of NPY (aPR 4.93; 95%CI 3.61,6.75) after adjusting for potential confounders.</p><p><strong>Conclusion: </strong>Majority of the PwTB received atleast one NPY instalment, but they experience significant delays. Most of the recipients utilised NPY for nutrition. Longitudinal follow-up studies are required to study the impact of NPY on treatment outcomes.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265306/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/16549716.2024.2363300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ni-kshay Poshan Yojana (NPY), a direct benefit transfer scheme under the National Tuberculosis Elimination Program (NTEP) in India, provides a monthly benefit of INR500 for nutritional support of persons with TB (PwTB).

Objectives: To determine the proportion of PwTB receiving atleast one NPY instalment and pattern of utilisation; to ascertain factors associated with NPY non-receipt and association of NPY receipt with TB treatment outcome.

Methods: In our cross-sectional study, we used multi-stage sampling to select PwTB whose treatment outcome was declared between May 2022 and February 2023. A cluster-adjusted, generalized linear model was used to identify factors associated with the non-receipt of NPY and determine association between NPY receipt and TB treatment outcome.

Results: Among 3201 PwTB, 2888 (92.7%; 95% CI 89.8%, 94.8%) had received at least one NPY instalment, and 1903 (64.2%; 95% CI 58.9%, 69.2%) self-reported receipt of benefit. The median (IQR) time to receipt of first instalment was 105 (60,174) days. Non-receipt was significantly higher among PwTB from states with low TB score (aPR = 2.34; 95%CI 1.51, 3.62), who do not have bank account (aPR = 2.48; 95%CI 1.93, 3.19) and with unknown/missing diabetic status (aPR = 1.69; 95%CI 1.11, 2.55). Unfavorable treatment outcomes were associated with non-receipt of NPY (aPR 4.93; 95%CI 3.61,6.75) after adjusting for potential confounders.

Conclusion: Majority of the PwTB received atleast one NPY instalment, but they experience significant delays. Most of the recipients utilised NPY for nutrition. Longitudinal follow-up studies are required to study the impact of NPY on treatment outcomes.

Ni-kshay Poshan Yojana:2022 年印度国家消除结核病计划通知的结核病患者的接收和使用情况。
背景:Ni-kshay Poshan Yojana(NPY)是印度国家肺结核消除计划(NTEP)下的一项直接福利转移计划,每月为肺结核患者(PwTB)提供 500 印度卢比的营养支持:目的:确定至少领取一次 NPY 的肺结核患者的比例和使用模式;确定未领取 NPY 的相关因素以及领取 NPY 与肺结核治疗结果的关系:在横断面研究中,我们采用了多阶段抽样法,选择了在 2022 年 5 月至 2023 年 2 月期间宣布治疗结果的肺结核患者。采用聚类调整的广义线性模型确定未接受 NPY 的相关因素,并确定接受 NPY 与结核病治疗结果之间的关联:在 3201 名肺结核患者中,2888 人(92.7%;95% CI 89.8%,94.8%)至少接受过一次 NPY 分期治疗,1903 人(64.2%;95% CI 58.9%,69.2%)自称接受过治疗。领取第一期津贴的时间中位数(IQR)为 105 (60,174) 天。来自结核病得分较低的州 (aPR = 2.34; 95%CI 1.51, 3.62)、没有银行账户 (aPR = 2.48; 95%CI 1.93, 3.19) 以及糖尿病状况未知/缺失 (aPR = 1.69; 95%CI 1.11, 2.55) 的肺结核患者未领取补助的比例明显较高。在调整了潜在的混杂因素后,不利的治疗结果与未接受 NPY 相关(aPR 4.93; 95%CI 3.61,6.75):大多数肺结核患者至少接受了一次 NPY 治疗,但他们的治疗被严重拖延。大多数接受者利用 NPY 补充营养。需要进行纵向跟踪研究,以了解 NPY 对治疗结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信